Small molecules & peptides

DOTA-TATE acetate (GMP)

Precursor for radiolabelled DOTA-[Tyr3]octreotate

DOTA-[Tyr3]-Octreotate, DOTA-[Tyr3, Thr8]-Octreotide

DOTA-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH, cyclic disulfide; DOTA = N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-; Supplied as acetate salt

Quality

GMP Product

Characteristics

Molar mass 1435.63

CAS RN [177943-89-4]

Purity ≥ 98.0 %

  • Colorless to off-white solid
  • Tested for bioburden and bacterial endotoxins.

Certificates

CoA: appearance, ESI-MS (identity), HPLC (purity), GC (residual solvents, acetate content, water content)

Product sheets (PDF)

Literature

De Jong M. et al. Combination Radionuclide Therapy Using ¹⁷⁷Lu- and ⁹⁰Y-Labeled Somatostatin Analogs. J. Nucl. Med., 2005, 46,13S

Valkema R. et al. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with ⁹⁰Y-DOTA⁰,Tyr³-Octreotide and ¹⁷⁷Lu-DOTA⁰,Tyr³-Octreotate. J. Nucl. Med.2005, 46, 8.

Add to inquiry

Product No.Filling amountQuantity
Product No.: 9772Filling amount: 25 µg
Product No.: 9772Filling amount: 50 µg
Product No.: 9772Filling amount: 100 µg
Product No.: 9772Filling amount: 250 µg
Product No.: 9772Filling amount: 400 µg
Product No.: 9772Filling amount: 1000 µg
Product No.: 9772

Related products

Product was added